Monoclonal gammopathy of undetermined significance
Monoclonal gammopathy of undetermined significanceArticle Sections
DefinitionMonoclonal gammopathy of undetermined significance (MGUS) is a condition in which an abnormal protein (monoclonal protein, or M protein) is in the blood. M protein is produced by plasma cells, a type of white blood cell. Monoclonal gammopathy of undetermined significance usually causes no problems. In some people, however, monoclonal gammopathy of undetermined significance is either associated with another disease or can progress over years to other disorders, including some forms of blood cancer. Because it's difficult to predict whose condition will progress, if you have monoclonal gammopathy of undetermined significance you'll usually have annual checkups to monitor your level of M protein. If there's no increase in the protein, monoclonal gammopathy doesn't require treatment. If monoclonal gammopathy of undetermined significance does progress, close monitoring leads to early diagnosis and treatment. SymptomsMonoclonal gammopathy of undetermined significance rarely causes signs or symptoms. The condition is usually detected by chance when you have a routine blood test for another problem. However, some people may experience nerve problems, such as numbness or tingling, associated with the abnormal protein. CausesPlasma cells are a type of white blood cell. They are found in your bone marrow. Plasma cells produce some of the antibodies that help your body fight infection. Monoclonal gammopathy of undetermined significance occurs when plasma cells in your bone marrow produce an abnormal protein called monoclonal protein (M protein). In the majority of people with monoclonal gammopathy of undetermined significance, the protein isn't harmful. But when too much M protein accumulates, it crowds out healthy cells in your bone marrow and can damage other tissues in your body. Genetic changes appear to play a role in monoclonal gammopathy of undetermined significance, as do environmental triggers, such as being exposed to certain pesticides or to radiation from an atomic bomb. Risk factorsFactors that increase your risk of monoclonal gammopathy of undetermined significance include:
ComplicationsIt's estimated that between 10 and 25 percent of people with monoclonal gammopathy of undetermined significance develop a more serious condition, such as multiple myeloma or other cancers or blood disorders. Doctors can't definitively predict who will go on to develop a more serious condition, but they can determine who has the greatest risk. Your doctor takes into account several factors when determining your risk, including:
Your risk of developing a more serious condition increases the longer you've had monoclonal gammopathy of undetermined significance. Other complications associated with monoclonal gammopathy of undetermined significance include fractures and blood clots. Preparing for your appointmentMost often, monoclonal gammopathy is detected and monitored with blood tests. These tests require drawing blood from a vein in your arm and require no preparation on your part. If you're found to have monoclonal gammopathy of undetermined significance, you may be referred to a hematologist, a doctor who specializes in blood disorders. It's a good idea to arrive well prepared for your appointment. Here's some information to help you get ready, and what you might expect from your doctor. What you can do
Your time with your doctor is limited, so preparing a list of questions can help you make the most of your time together. List your questions from most important to least important in case time runs out. For monoclonal gammopathy of undetermined significance, some basic questions include:
In addition to the questions that you've prepared to ask your doctor, don't hesitate to ask additional questions during your appointment.
What to expect from your doctor
Tests and diagnosisMonoclonal gammopathy of undetermined significance is usually detected during a blood test for another condition or symptoms, such as a nerve condition called peripheral neuropathy or an unexplained rash. The test, called serum protein electrophoresis (SPE), separates your blood proteins into five parts and can show any abnormal proteins as well as unusual amounts of normal proteins. Another test, the free light chain assay, is often done at the same time as the SPE, and it looks at the smaller parts of the M protein. If your doctor detects monoclonal gammopathy, further testing may be ordered to determine what M protein your body is making and how much is being made. Your doctor also works to rule out other causes of elevated protein levels. Tests may include:
Treatments and drugsMonoclonal gammopathy of undetermined significance doesn't require treatment, but your doctor is likely to recommend frequent checkups to monitor your health. A checkup every six to 12 months may be appropriate for most people. If you have a high risk of developing a more serious condition, your doctor may recommend more frequent checkups so that if a disease such as multiple myeloma develops, it can be treated as early as possible. If you have monoclonal gammopathy of undetermined significance and bone loss, your doctor may recommend treatment with medications called bisphosphonates that help increase your bone density. Examples of bisphosphonates include alendronate (Fosamax), risedronate (Actonel), ibandronate (Boniva) and zoledronic acid (Reclast, Zometa). Coping and supportAlthough you can't control whether monoclonal gammopathy of undetermined significance will lead to something more serious, you can control many aspects of your health. The following suggestions may help:
PreventionRight now, the cause of monoclonal gammopathy of undetermined significance is unknown, so there is no way to prevent monoclonal gammopathy of undetermined significance and no way to stop it from progressing to a more serious condition. Last Updated: 2010-12-04 © 1998-2013 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "Mayo Clinic Health Information," "Reliable information for a healthier life" and the triple-shield Mayo logo are trademarks of Mayo Foundation for Medical Education and Research.
Terms and conditions of use |
|
|
|
|



